<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2019 [PPXK5GW761L0VHT4GKPY]. www.edgarsuite.com -->
<HEAD>
<TITLE>Submission Proof - X:\2019 OPERATIONS\2019 EDGAR\07 July\Wall Street Media Co Inc\07-18-2019\Form 8-k\Draft\Production\Wall Street Media Co Inc Form 8-k.gfp</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P style='font:1pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>&#160;</B></P>
<P align=center style='font:18pt Times New Roman;margin:0'><FONT style=font-size:18pt><B>UNITED STATES</B></FONT></P>
<P align=center style='font:18pt Times New Roman;margin:0'><FONT style=font-size:18pt><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Washington, D.C. 20549</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:18pt Times New Roman;margin:0'><FONT style=font-size:18pt><B>FORM 8-K</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>&#160;</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Current Report</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>&#160;</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>Date of Report (Date of earliest event reported)</I>: <B>August 10, 2019</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>&#160;</B></P>
<P align=center style='font:18pt Times New Roman;margin:0'><FONT style=font-size:18pt><B>GB Sciences, Inc.</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>(Exact name of registrant as specified in its charter)</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>&#160;</I></P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><B>Nevada</B></P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><B>000-55462</B></P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><B>59-3733133</B></P>
</TD></TR>
<TR><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><I>(State or other jurisdiction</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>of incorporation)</I></P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><I>(Commission</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>File Number)</I></P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><I>(IRS Employer</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>Identification No.)</I></P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'><I>&#160;</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>3550 W. Teco Avenue</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Las Vegas, Nevada 89118</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>(Address of principal executive offices and zip code)</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>&#160;</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Phone: (866) 721-0297</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I> (Registrant&#8217;s telephone number, including area code)</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>&#160;</I></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:18pt><P style='font:10pt Times New Roman;margin:0'>[&#160;&#160;]</P>
</TD><TD valign=top><P align=justify style='font:10pt Times New Roman;margin:0'>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P align=justify style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>[&#160;&#160;]</P>
</TD><TD valign=top><P align=justify style='font:10pt Times New Roman;margin:0'>&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P align=justify style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>[&#160;&#160;]</P>
</TD><TD valign=top><P align=justify style='font:10pt Times New Roman;margin:0'>&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P align=justify style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>[&#160;&#160;]</P>
</TD><TD valign=top><P align=justify style='font:10pt Times New Roman;margin:0'>Pre-commencement to medications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Securities registered pursuant to Section 12(b) of the Act:</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=bottom style='border-bottom:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>Title of each class</B></P>
</TD><TD valign=bottom style=padding-bottom:1.5pt><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style='border-bottom:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>Trading Symbol(s)</B></P>
</TD><TD valign=bottom style=padding-bottom:1.5pt><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style='border-bottom:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>Name of each exchange on which registered</B></P>
</TD></TR>
<TR><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>N/A</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom><P align=center style='font:10pt Times New Roman;margin:0'>N/A</P>
</TD><TD valign=bottom><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom><P align=center style='font:10pt Times New Roman;margin:0'>N/A</P>
</TD></TR>
</TABLE>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter). &nbsp;&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Emerging Growth Company [&#160;&#160;]</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:13.5pt'>&#160;</P>
<HR style='page-break-after:always;border:0;height:3.75pt;background-color:#919191;margin:15pt 0'><P style=line-height:0;margin:0></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&#160;&#160;]</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000'><B>Item 4.01 &nbsp;Change in Registrant&#8217;s Certifying Accountant.</B></P>
<P style='font:10pt Times New Roman;margin:0'><B>&#160;</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On August 10, 2019, GB Sciences, Inc. a Nevada corporation (&#8220;we,&#8221; &#8220;us,&#8221; our&#8221; or the &#8220;Company&#8221;)  formally engaged Assurance Dimensions, Inc. as our independent registered public accounting firm. The engagement was due to the recent acquisition of Soles Heyn &amp; Company, LLP&#8217;s (SHCPA) SEC practice by Assurance Dimensions, Inc.; SHCPA was our independent registered public accounting firm until the engagement of Assurance Dimensions, Inc. The decision to engage Assurance Dimensions, Inc. as our independent registered public accounting firm was approved by the Board of Directors on August 15, 2019.</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>The Company has provided SHCPA with a copy of the disclosures in this Current Report on Form 8-K prior to its filing with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and has requested that SHCPA furnish it with a letter addressed to the SEC stating whether or not it agrees with the statements in this Item 4.01 of this Form 8-K. SHCPA has provided the Company, prior to its filing with the SEC, with a letter addressed to the SEC stating it agrees with the statements in this Item 4.01 of this Form 8-K. A copy of the letter is filed concurrently herewith as Exhibit 16.1. &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>SHCPA&#8217;s report on the Company&#8217;s financial statements for the fiscal years ended March 31, 2019 and March 31, 2018 did not contain any adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles, except as set forth herein. SHCPA&#8217;s reports on the Company&#8217;s financial statements for the fiscal years ended March 31, 2019 and March 31, 2018 contained an explanatory paragraph regarding the significant doubt about the Company&#8217;s ability to continue as a going concern.</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>During the two-year period ended March 31, 2019 and the subsequent period through the date of filing of this report, (i) there have been no disagreements with SHCPA, whether or not resolved, on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of SHCPA, would have caused SHCPA to make reference to the subject matter of the disagreement in connection with its reports; (ii) no such disagreement was discussed with the audit committee of the Company&#8217;s board of directors or with our board of directors as a whole; and (iii) there have been no &#8220;reportable events&#8221; as described in Item 304(a)(1)(v) of Regulation S-K.</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>During the two most recent fiscal years and through the engagement date, we did not consult with Assurance Dimensions, Inc. regarding either (1) the application of accounting principles to any specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on our financial statements or (2) any matter that was either the subject of a disagreement or a reportable event as defined in Item 304(a)(1)(iv) and (v) of Regulation S-K.</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<HR style='page-break-after:always;border:0;height:3.75pt;background-color:#919191;margin:15pt 0'><P style=line-height:0;margin:0></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0'><B>Item 9.01. Financial Statements and Exhibits.</B></P>
<P style='font:10pt Times New Roman;margin:0'>&#160;&#160;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top style='width:54pt;border-bottom:1.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0'><B>Exhibit No.</B></P>
</TD><TD valign=top style=width:7.2pt;padding-bottom:1.5pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style='border-bottom:1.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0'><B>Document</B></P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF><P align=justify style='font:10pt Times New Roman;margin:0'>16.1*</P>
</TD><TD valign=top bgcolor=#FFFFFF><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top bgcolor=#FFFFFF><P align=justify style='font:10pt Calibri;margin:0'><A href=gblx_ex16z1.htm style=text-decoration:none><FONT style='font:10pt Times New Roman;color:#0000FF;border-bottom:1px solid #0000FF'>Letter to Securities and Exchange Commission from Soles, Heyn &amp; Company dated August 14, 2019</FONT></A></P>
</TD></TR>
</TABLE>
<P align=justify style='font:10pt Times New Roman;margin:0'>&#160;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;*Filed herewith. </P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
</TABLE>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>SIGNATURES</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>&#160;</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&#160;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'><B>GREENWAY TECHNOLOGIES, INC.</B></P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>Dated: August 15, 2019</P>
</TD><TD valign=top style='border-bottom:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>/s/ John Poss</I></P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>John Poss</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>Chief Executive Officer</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "gblx_8k.htm", "description": "8-K", "secsgml_size_bytes": 16983}]
{"company-data": {"conformed-name": "GB SCIENCES INC", "cik": "0001165320", "assigned-sic": "1311", "irs-number": "593733133", "state-of-incorporation": "DE", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-55462", "film-number": "191030385"}, "business-address": {"street1": "6450 CAMERON STREET #110A", "city": "LAS VEGAS", "state": "NV", "zip": "89118", "phone": "(844) 843-2569"}, "mail-address": {"street1": "6450 CAMERON STREET #110A", "city": "LAS VEGAS", "state": "NV", "zip": "89118"}, "former-company": [{"former-conformed-name": "Growblox Sciences, Inc.", "date-changed": "20140603"}, {"former-conformed-name": "Signature Exploration & Production Corp.", "date-changed": "20080602"}, {"former-conformed-name": "Diabetic Treatment Centers of America, Inc.", "date-changed": "20040812"}]}
Submission Proof - X:\2019 OPERATIONS\2019 EDGAR\07 July\Wall Street Media Co Inc\07-18-2019\Form 8-k\Draft\Production\Wall Street Media Co Inc Form 8-k.gfp
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
:
August 10, 2019
GB Sciences, Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-55462
59-3733133
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
3550 W. Teco Avenue
Las Vegas, Nevada 89118
(Address of principal executive offices and zip code)
Phone: (866) 721-0297
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]
Pre-commencement to medications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
N/A
N/A
N/A
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging Growth Company [  ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]
Item 4.01  Change in Registrant's Certifying Accountant.
On August 10, 2019, GB Sciences, Inc. a Nevada corporation ("we," "us," our" or the "Company")  formally engaged Assurance Dimensions, Inc. as our independent registered public accounting firm. The engagement was due to the recent acquisition of Soles Heyn & Company, LLP's (SHCPA) SEC practice by Assurance Dimensions, Inc.; SHCPA was our independent registered public accounting firm until the engagement of Assurance Dimensions, Inc. The decision to engage Assurance Dimensions, Inc. as our independent registered public accounting firm was approved by the Board of Directors on August 15, 2019.
The Company has provided SHCPA with a copy of the disclosures in this Current Report on Form 8-K prior to its filing with the Securities and Exchange Commission (the "SEC") and has requested that SHCPA furnish it with a letter addressed to the SEC stating whether or not it agrees with the statements in this Item 4.01 of this Form 8-K. SHCPA has provided the Company, prior to its filing with the SEC, with a letter addressed to the SEC stating it agrees with the statements in this Item 4.01 of this Form 8-K. A copy of the letter is filed concurrently herewith as Exhibit 16.1.
SHCPA's report on the Company's financial statements for the fiscal years ended March 31, 2019 and March 31, 2018 did not contain any adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles, except as set forth herein. SHCPA's reports on the Company's financial statements for the fiscal years ended March 31, 2019 and March 31, 2018 contained an explanatory paragraph regarding the significant doubt about the Company's ability to continue as a going concern.
During the two-year period ended March 31, 2019 and the subsequent period through the date of filing of this report, (i) there have been no disagreements with SHCPA, whether or not resolved, on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of SHCPA, would have caused SHCPA to make reference to the subject matter of the disagreement in connection with its reports; (ii) no such disagreement was discussed with the audit committee of the Company's board of directors or with our board of directors as a whole; and (iii) there have been no "reportable events" as described in Item 304(a)(1)(v) of Regulation S-K.
During the two most recent fiscal years and through the engagement date, we did not consult with Assurance Dimensions, Inc. regarding either (1) the application of accounting principles to any specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on our financial statements or (2) any matter that was either the subject of a disagreement or a reportable event as defined in Item 304(a)(1)(iv) and (v) of Regulation S-K.
Item 9.01. Financial Statements and Exhibits.
Exhibit No.
Document
16.1*
Letter to Securities and Exchange Commission from Soles, Heyn & Company dated August 14, 2019
*Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
GREENWAY TECHNOLOGIES, INC.
Dated: August 15, 2019
/s/ John Poss
John Poss
Chief Executive Officer